Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I—II Randomized Clinical Trial

BACKGROUND: Dose-sparing strategies are being explored for vaccines against pandemic influenza. We evaluated the dose-sparing potential of aluminum hydroxide (AlOH) adjuvant. METHODS: A total of 600 healthy subjects (age, 18–49 years) were randomized to receive 2 vaccinations 1 month apart with subv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Keitel, Wendy A., Campbell, James D., Treanor, John J., Walter, Emmanuel B., Patel, Shital M., He, Fenhua, Noah, Diana L., Hill, Heather
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3044935/
https://ncbi.nlm.nih.gov/pubmed/18808338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/592172
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados